Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

242 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Purification and partial characterization of membrane-associated type II (cGMP-activatable) cyclic nucleotide phosphodiesterase from rabbit brain.
Whalin ME, Strada SJ, Thompson WJ. Whalin ME, et al. Among authors: thompson wj. Biochim Biophys Acta. 1988 Oct 28;972(1):79-94. doi: 10.1016/0167-4889(88)90105-x. Biochim Biophys Acta. 1988. PMID: 2846074
Suppression of cyclic GMP-specific phosphodiesterase 5 promotes apoptosis and inhibits growth in HT29 cells.
Zhu B, Vemavarapu L, Thompson WJ, Strada SJ. Zhu B, et al. Among authors: thompson wj. J Cell Biochem. 2005 Feb 1;94(2):336-50. doi: 10.1002/jcb.20286. J Cell Biochem. 2005. PMID: 15526282
Characterization of 3',5' cyclic nucleotide phosphodiesterase activity in Y79 retinoblastoma cells: absence of functional PDE6.
White JB, Thompson WJ, Pittler SJ. White JB, et al. Among authors: thompson wj. Mol Vis. 2004 Oct 6;10:738-49. Mol Vis. 2004. PMID: 15480303
Phosphodiesterase 3 activity is reduced in dog lung following pacing-induced heart failure.
Tarpey SB, Sawmiller DR, Kelly C, Thompson WJ, Townsley MI. Tarpey SB, et al. Among authors: thompson wj. Am J Physiol Lung Cell Mol Physiol. 2003 May;284(5):L766-73. doi: 10.1152/ajplung.00373.2002. Epub 2003 Jan 10. Am J Physiol Lung Cell Mol Physiol. 2003. PMID: 12676767
Activation and induction of cyclic AMP phosphodiesterase (PDE4) in rat pulmonary microvascular endothelial cells.
Zhu B, Kelly J, Vemavarapu L, Thompson WJ, Strada SJ. Zhu B, et al. Among authors: thompson wj. Biochem Pharmacol. 2004 Aug 1;68(3):479-91. doi: 10.1016/j.bcp.2004.03.039. Biochem Pharmacol. 2004. PMID: 15242814
Reversal of pulmonary capillary ischemia-reperfusion injury by rolipram, a cAMP phosphodiesterase inhibitor.
Barnard JW, Seibert AF, Prasad VR, Smart DA, Strada SJ, Taylor AE, Thompson WJ. Barnard JW, et al. Among authors: thompson wj. J Appl Physiol (1985). 1994 Aug;77(2):774-81. doi: 10.1152/jappl.1994.77.2.774. J Appl Physiol (1985). 1994. PMID: 8002527
A novel cyclic GMP stimulated phosphodiesterase from rat brain.
Yang Q, Paskind M, Bolger G, Thompson WJ, Repaske DR, Cutler LS, Epstein PM. Yang Q, et al. Among authors: thompson wj. Biochem Biophys Res Commun. 1994 Dec 30;205(3):1850-8. doi: 10.1006/bbrc.1994.2886. Biochem Biophys Res Commun. 1994. PMID: 7811274
Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic-3',5'-guanosine monophosphate-stimulated phosphodiesterase to reverse hypoxic pulmonary vasoconstriction in the perfused rat lung.
Haynes J Jr, Killilea DW, Peterson PD, Thompson WJ. Haynes J Jr, et al. Among authors: thompson wj. J Pharmacol Exp Ther. 1996 Feb;276(2):752-7. J Pharmacol Exp Ther. 1996. PMID: 8632346
Functional identification of phosphodiesterase activity in human trabecular meshwork cells.
Zhou L, Thompson WJ, Potter DE. Zhou L, et al. Among authors: thompson wj. J Ocul Pharmacol Ther. 2000 Aug;16(4):317-22. doi: 10.1089/jop.2000.16.317. J Ocul Pharmacol Ther. 2000. PMID: 10977127
Inhibition of gastric acid secretion in vivo and in vitro by a new calmodulin antagonist, CGS 9343B.
Black EW, Strada SJ, Garrett RL Jr, Kvietys PR, Thompson WJ, Norman JA. Black EW, et al. Among authors: thompson wj. J Pharmacol Exp Ther. 1989 Jan;248(1):208-14. J Pharmacol Exp Ther. 1989. PMID: 2464057
242 results
Jump to page
Feedback